Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Functional and Long-Term Survival Data of AMX0035 in Amyotrophic Lateral Sclerosis: Results of the CENTAUR Trial
Neurotherapeutics · Vol. 18, pp. 2139-2140 Published January 1, 2021
More on these topics
Browse all publications →-
2019 · Alzheimer's & Dementia
P4-023: CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER'S DISEASE
-
2026 · Stat Med.
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases
-
2026 · Neurol Ther
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)
-
2025 · CNS Drugs
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer’s Disease: Synthesis of Evidence from Observational and Interventional Trials